Skip to main content
. Author manuscript; available in PMC: 2024 Apr 1.
Published in final edited form as: Cytotherapy. 2023 Jan 27;25(4):442–450. doi: 10.1016/j.jcyt.2022.12.006

Table 1. Sepax and COBE Red Blood Cell Volume Reductions.

Red blood cell (RBC) volumes before and after processing for both the Sepax and the COBE. Values from each run are shown along with the average of each individual column. Three runs were carried out for the 10x comparison, and two runs for the 12x and 15x comparison runs.

Reduction N Sepax RBC
pre-
Volume
(mL)
Sepax
RBC post
Volume
(mL)
COBE
RBC pre-
Volume
(mL)
COBE
RBC post
Volume
(mL)
Sepax
RBC
Volume
Reduction
(%)
COBE RBC
Volume
Reduction
(%)
10x comparison 3 76.82 22.39 84.60 19.37 70.85 77.10
166.40 6.00 175.10 10.70 96.39 93.89
173.04 15.66 172.54 9.83 90.95 94.30
Avg: 138.75 Avg: 14.68 Avg: 144.08 Avg: 13.3 Avg: 86.06 Avg: 88.43
12x comparison 2 176.00 0.83 182.00 22.56 99.53 87.60
164.85 3.20 168.44 2.194 98.06 98.70
Avg: 170.42 Avg: 2.02 Avg: 175.22 Avg: 12.38 Avg: 98.80 Avg: 93.15
15x comparison 2 178.84 2.06 180.24 55.92 98.80 69.00
187.78 1.92 189.55 37.26 98.98 80.30
Avg: 183.31 Avg: 1.99 Avg: 184.89 Avg: 46.59 Avg: 98.89 Avg: 74.65